Jiangsu Hengrui Pharmaceuticals Co.,Ltd

SZSC:1276 Stock Report

Market Cap: HK$450.3b

Jiangsu Hengrui PharmaceuticalsLtd Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

SZSC:1276 Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
04 Nov 25BuyHK$62,151,724Wellington Management Group LLPCompany855,600HK$72.64
03 Nov 25BuyHK$4,562,433JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany62,048HK$73.53
03 Nov 25SellHK$25,941,631JP Morgan Asset ManagementCompany352,800HK$73.53
31 Oct 25SellHK$67,409,913JP Morgan Asset ManagementCompany898,800HK$75.00
31 Oct 25SellHK$124,971,064JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,666,283HK$75.00
30 Oct 25BuyHK$74,550,812Wellington Management Group LLPCompany1,012,231HK$73.65
30 Oct 25BuyHK$31,572,877GIC Private LimitedCompany430,000HK$73.43
30 Oct 25BuyHK$460,844,529JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany6,263,934HK$73.57
28 Oct 25SellHK$96,517,270JP Morgan Asset ManagementCompany1,269,782HK$76.01
16 Oct 25SellHK$253,099,865JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,058,387HK$82.76
13 Oct 25BuyHK$40,254,005GIC Private LimitedCompany486,200HK$82.79
09 Oct 25SellHK$39,782,164JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany452,179HK$87.98
26 Sep 25BuyHK$100,965,553JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,161,565HK$86.92
23 Sep 25SellHK$125,456,106JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,430,392HK$87.71
19 Sep 25BuyHK$150,849,918Capital Research and Management CompanyCompany1,728,200HK$87.29
15 Sep 25SellHK$44,139,447UBS Asset Management AGCompany546,400HK$80.78
11 Sep 25BuyHK$206,494,262GIC Private LimitedCompany2,519,000HK$81.97
11 Sep 25SellHK$372,763,193JP Morgan Asset ManagementCompany4,653,630HK$80.10
08 Sep 25BuyHK$17,554,873UBS Asset Management AGCompany204,400HK$85.88
05 Sep 25SellHK$50,279,799JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany595,961HK$84.37
05 Sep 25SellHK$63,417,833UBS Asset Management AGCompany741,150HK$85.57
03 Sep 25BuyHK$270,500,109JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany3,164,599HK$85.48
29 Aug 25BuyHK$211,670,838JP Morgan Asset ManagementCompany2,811,336HK$75.29
19 Aug 25SellHK$48,875,209JP Morgan Asset ManagementCompany607,153HK$80.50
19 Aug 25SellHK$76,053,609UBS Asset Management AGCompany944,200HK$80.55
14 Aug 25BuyHK$252,324JPMorgan Chase & Co, Private Banking and Investment Banking InvestmentsCompany3,200HK$78.85
14 Aug 25BuyHK$22,010,737JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany279,142HK$78.85
13 Aug 25SellHK$112,995,014JP Morgan Asset ManagementCompany1,460,450HK$77.37
04 Aug 25BuyHK$143,274,495JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,859,201HK$77.06
04 Aug 25SellHK$56,909,673UBS Asset Management AGCompany740,300HK$76.87
01 Aug 25SellHK$19,412,346JP Morgan Asset ManagementCompany251,313HK$77.24
30 Jul 25SellHK$87,395,754GIC Private LimitedCompany1,071,800HK$81.54
29 Jul 25SellHK$170,001,297GIC Private LimitedCompany2,058,800HK$82.57
25 Jul 25SellHK$77,955,636Capital Research and Management CompanyCompany1,119,200HK$69.65
22 Jul 25SellHK$14,931,973Invesco Ltd.Company206,200HK$72.41
11 Jul 25BuyHK$84,930,114Wellington Management Group LLPCompany1,140,000HK$74.50
10 Jul 25SellHK$11,872,615Wellington Management Group LLPCompany160,462HK$73.99
08 Jul 25BuyHK$139,835,208JP Morgan Asset ManagementCompany2,285,819HK$61.18
08 Jul 25SellHK$97,619,254Invesco Ltd.Company1,590,600HK$61.37
08 Jul 25SellHK$23,216,425UBS Asset Management AGCompany380,800HK$60.97
26 Jun 25BuyHK$20,325,452Wellington Management Group LLPCompany362,460HK$56.08
26 Jun 25BuyHK$17,918,960GIC Private LimitedCompany317,600HK$56.42
24 Jun 25BuyHK$12,043,155Wellington Management Group LLPCompany211,388HK$56.97
24 Jun 25SellHK$15,852,101JP Morgan Asset ManagementCompany277,550HK$57.11
16 Jun 25BuyHK$83,854,831JP Morgan Asset ManagementCompany1,421,302HK$59.00
06 Jun 25BuyHK$14,496,368Wellington Management Group LLPCompany253,000HK$57.30
06 Jun 25SellHK$106,794,792Invesco Ltd.Company1,863,000HK$57.32
04 Jun 25SellHK$150,322,512Invesco Ltd.Company2,589,000HK$58.06
03 Jun 25BuyHK$10,862,525JP Morgan Asset ManagementCompany189,600HK$57.29
30 May 25BuyHK$149,312,774Morgan Stanley, Investment Banking and Brokerage InvestmentsCompany2,583,610HK$57.79
30 May 25BuyHK$13,533,881GIC Private LimitedCompany234,400HK$57.74
29 May 25SellHK$18,368,249UBS Asset Management AGCompany335,720HK$54.71
29 May 25SellHK$32,884,859JP Morgan Asset ManagementCompany582,600HK$56.45
28 May 25BuyHK$41,891,777JP Morgan Asset ManagementCompany746,000HK$56.16
28 May 25SellHK$6,401,692JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany114,000HK$56.16
27 May 25BuyHK$18,152,583JP Morgan Asset ManagementCompany330,313HK$54.96
23 May 25BuyHK$966,824,072Capital Research and Management CompanyCompany19,749,200HK$48.96
23 May 25BuyHK$428,330,425JP Morgan Asset ManagementCompany7,470,232HK$57.34
23 May 25BuyHK$95,374,985JPMorgan Chase & Co, Brokerage and Securities InvestmentsCompany1,663,373HK$57.34
23 May 25BuyHK$1,162,497,130Invesco Ltd.Company26,390,400HK$44.05

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 1276?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders7,843,0540.118%
Employee Share Scheme35,700,0000.539%
Institutions1,728,427,77626.1%
General Public1,968,820,67829.7%
Private Companies2,884,149,25643.5%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 64.89% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
23.2%
Jiangsu Hengrui Medicine Group Co., Ltd.
1,538,184,187HK$104.5b0%no data
14.4%
Tibet Dagze Huixin Investment Management Partnership (Limited Partnership)
952,752,304HK$64.8b0%no data
5.88%
Hong Kong Exchanges and Clearing Limited
389,525,860HK$26.5b0%3.29%
3.09%
China National Pharmaceutical Group Corporation
204,669,209HK$13.9b-8.2%no data
2.74%
Qingdao Bosentai Investment Partnership Enterprise (Limited Partnership)
181,506,156HK$12.3b-0.18%no data
1.66%
Lianyungang Financial Holding Group Co., Ltd.
109,787,876HK$7.5b-1.81%no data
1.44%
China Securities Finance Corporation Limited
95,399,822HK$6.5b0%0.89%
1.36%
China Universal Asset Management Company Ltd.
90,311,019HK$6.1b-0.03%1.92%
1.32%
China Asset Management Co. Ltd.
87,616,096HK$6.0b7.2%0.6%
1.2%
Huatai-PineBridge Fund Management Co., Ltd.
79,499,531HK$5.4b3.17%1.0%
1.19%
E Fund Management Co., Ltd.
79,036,142HK$5.4b0%0.52%
1.05%
Zhong Ou Fund Management Co., Ltd
69,779,796HK$4.7b0%1.9%
0.97%
ICBC Credit Suisse Fund Management Co., Ltd
64,049,049HK$4.4b0%2.33%
0.82%
GIC Private Limited
54,422,600HK$3.7b5.31%0.8%
0.65%
Harvest Fund Management Co. Ltd.
42,808,327HK$2.9b0%0.55%
0.63%
Capital Research and Management Company
41,464,135HK$2.8b-6.25%0.02%
0.54%
Jiangsu Hengrui Medicine Co., Ltd., ESOP
35,700,000HK$2.4b0%no data
0.48%
GF Fund Management Co., Ltd.
31,607,702HK$2.1b0%0.43%
0.45%
Yinhua Fund Management Co., Ltd.
29,784,230HK$2.0b-0.25%1.39%
0.39%
BlackRock, Inc.
25,989,755HK$1.8b13.2%no data
0.31%
Guotai Asset Management Company Limited
20,586,279HK$1.4b-0.03%0.57%
0.31%
HuaAn Fund Management Company Ltd.
20,396,227HK$1.4b0%0.55%
0.29%
Wellington Management Group LLP
19,012,140HK$1.3b38.9%0.03%
0.28%
The Vanguard Group, Inc.
18,233,683HK$1.2b1.89%no data
0.25%
Penghua Fund Management Co., Ltd.
16,730,232HK$1.1b0%0.66%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/12 03:41
End of Day Share Price 2025/11/12 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Jiangsu Hengrui Pharmaceuticals Co.,Ltd is covered by 46 analysts. 25 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Bo LiBofA Global Research
Yanan HouBohai Securities Co., Ltd.
Shun Kei LawCCB International Securities Limited